HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds AstraZeneca (AZN) Investors of Pending Securities Class Action, Encourages Investors Who Suffered Losses to Contact the Firm
01. März 2021 17:35 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges AstraZeneca PLC (NASDAQ: AZN) investors to submit their losses now. A securities fraud class action has been filed and certain...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds AstraZeneca (AZN) Investors of Securities Fraud Case Related to Potential COVID-19 Treatment Filed
16. Februar 2021 20:07 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges AstraZeneca PLC (NASDAQ: AZN) investors to submit their losses now. A securities fraud class action has been filed and certain...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Invites AstraZeneca (AZN) Investors to Contact Firm, Securities Fraud Case Related to Potential COVID-19 Treatment Filed
28. Januar 2021 15:50 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges AstraZeneca PLC (NASDAQ: AZN) investors to submit their losses now. A securities fraud lawsuit has been filed and certain...